Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors

Serum biomarker monitoring is essential for management of germ‐cell tumors (GCT). However, not all GCT are positive for conventional tumor markers. We examined whether serum N‐glycan‐based biomarkers can be applied for detection and prognosis in patients with GCT. We performed a comprehensive N‐glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Takuma, Hatakeyama, Shingo, Yoneyama, Tohru, Narita, Shintaro, Yamashita, Shinichi, Mitsuzuka, Koji, Sakurai, Toshihiko, Kawamura, Sadafumi, Tochigi, Tatsuo, Takahashi, Ippei, Nakaji, Shigeyuki, Tobisawa, Yuki, Yamamoto, Hayato, Koie, Takuya, Tsuchiya, Norihiko, Habuchi, Tomonori, Arai, Yoichi, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387168/
https://www.ncbi.nlm.nih.gov/pubmed/28317343
http://dx.doi.org/10.1002/cam4.1035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387168/
https://www.ncbi.nlm.nih.gov/pubmed/28317343
http://dx.doi.org/10.1002/cam4.1035

Ejemplares similares